US Stocks
/
ImageneBio, Inc. Share Price
ImageneBio, Inc. Share Price

ImageneBio, Inc. Share Price

NASDAQ: IMA | Micro Cap
$4.96
+$0.04 (0.91%) Last updated on 17 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ImageneBio, Inc. Stock Performance

Open
$5.13
Prev. Close
$4.92
Circuit Range
N/A
Day Range
$5.06 - $5.18
Year Range
$4.01 - $9.01
Volume
696
Average Traded
$5.10

ImageneBio, Inc. Share Price Today

As of 19 September 2026, ImageneBio, Inc.'s share price is $4.96. The stock opened at $5.13, compared to its previous close of $4.92. During today's trading session, ImageneBio, Inc.'s share price traded between $5.06 and $5.18, with an average price of $5.12. Over the past 52 weeks, the stock has recorded a high of $9.01 and a low of $4.01. In terms of performance, ImageneBio, Inc.'s share price has risen by 3.65% over the last six months and is down 37.82% on a year-on-year basis.

ImageneBio, Inc. Share Price Chart

$5.06$5.18
L
Show Current Price
H

ImageneBio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$24.18M
PE Ratio (TTM)
-0.52
Dividend Yield
N/A
EPS (TTM)
$-9.64
Revenue (TTM)
$800000.00
Return On Equity (TTM)
-34.06%
Profit Margin
-5668.63%
Debt to Equity
0.08
Quarterly Earnings Growth YoY
-142.12%

ImageneBio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/A
Net Profit-$13.73M-$10.23M-$8.62M-$2.77M-$24.78M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A25.46%15.78%67.90%-795.52%

ImageneBio, Inc. Annual Profit & Loss

All figures in USD

Particulars2021202220232025
Revenue$30.98M$15.62M$9.16M$800000.00
Net Profit-$34.12M-$68.77M-$68.17M-$45.35M
Net Profit Margin-110.10%-440.29%-744.17%-5668.63%
Income ChangeN/A-101.57%0.87%33.47%

About ImageneBio, Inc.

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. Its lead product includes IMG-007, a non-depleting anti-OX40 mAb that has completed Phase 2a clinical trials for the treatment of atopic dermatitis and alopecia areata. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

ImageneBio, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$4.96
$5.07
-8.24%
Aug 2026
$5.33
$5.53
-3.07%
Jul 2026
$5.81
$5.70
-6.25%
Jun 2026
$5.56
$6.08
+3.40%
May 2026
$5.89
$5.88
-2.81%
Apr 2026
$4.96
$6.05
+26.30%
Mar 2026
$6.24
$4.79
-31.47%
Feb 2026
$7.23
$6.99
-6.68%
Jan 2026
$6.87
$7.49
+9.02%
Dec 2025
$6.71
$6.87
-3.24%
Nov 2025
$8.30
$7.10
-17.35%
Oct 2025
$8.48
$8.59
+7.58%

IMA Share Price FAQs

What is ImageneBio, Inc. share price today?

chevron-up
ImageneBio, Inc. share price today is $4.96 as on September 17, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of ImageneBio, Inc. stock?

chevron-up
The 52 week high of ImageneBio, Inc. stock is $9.01, while the 52 week low is $4.01 as of 17 Sep '26.

What is IMA's market capitalisation today?

chevron-up
IMA market capitalisation is $24.18M as of September 19, 2026, at 3:35 am IST.

What is IMA's net income for the last quarter?

chevron-up
IMA's net income for the last quarter is -0.02B USD.

What is the 5 year returns of IMA?

chevron-up
The 5 year returns of IMA is -67.91% as on 17 Sep '26.

What is the high & low stock price of IMA today?

chevron-up
IMA stock price hit a high of $5.18 and low of $5.06 as of 17 Sep '26.

Can I buy IMA shares in India?

chevron-up
Yes. You can buy IMA in India by opening an international trading account.